NEFL and Parkinson disease: For CSF and blood biomarkers, CSF α-syn (P = 0.01), Aβ42 (P = 0.05), and t-tau (P = 0.003) were lower in the PD group compared to control group, but serum NFL levels were higher in the de novo PD group than control.